TrialRheumatology (Oxford, England)2022

A pilot study to evaluate the safety and efficacy of treprostinil in the treatment of calcinosis in systemic sclerosis.

Melody P Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.